23.09.2016 • NewsElaine BurridgePetrobrasPetrochemicals

Brazil’s Petrobras to Exit Petrochemicals

(c) kodda/Getty Images
(c) kodda/Getty Images

Brazilian oil giant Petrobras is planning to exit its petrochemical investments and other activities as it seeks to accelerate its debt reduction. The troubled Rio de Janeiro-based group is now said to rank as the world’s most heavily indebted oil producer, with gross debt of around $124 billion. The move will allow Petrobras to concentrate on its core businesses of oil and gas exploration and production, and refining.  President Pedro Parente said the next two years will be focused on recovering financial strength as an integrated energy company focused on oil and gas.

Petrobras has not specified which petrochemicals investments it will quit. However, it has already said it intends to exit biofuels and fertilizer production as well as the distribution of liquefied petroleum gas. Negotiations to sell the group’s stakes in PTA/PET producers Petroquimica Suape and Citepe to Mexican polyester producer Alpek began in July of this year. Petrobras also owns shares in polyolefins producer Braskem.

The state-controlled oil group plans to raise $19.5 billion from divestments in 2017 and 2018, in addition to the $15.1 billion targeted for the two years through the end of 2016. Parente revealed the plans as he outlined Petrobras’ strategy for the next five years. He has cut investment by 25% to $ 74.1 billion between 2017 and 2021, the lowest level in a decade, and he wants the group to lower its leverage from 5.3 times EBITDA in 2015 to 2.5 times in 2018.

The energy producer has been at the center of Brazil’s “Car Wash” corruption scandal which hit the headlines in March 2014, engulfing Petrobras executives and politicians from all major parties.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.